[
  {
    "ts": null,
    "headline": "BrainsWay Reports Cigna’s Evernorth Behavioral Health to Eliminate Prior Authorization Requirements for TMS Coverage, Accelerating Access to Care",
    "summary": "BURLINGTON, Mass. and JERUSALEM, Feb. 18, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today commented on the recent news issued by Evernorth® Behavioral Health, Inc., a division of the Cigna Group, which serves over 18 million covered lives across 12 states, that it will no longer require prior authorization for transcranial magnetic stimulation (TMS) for contracted providers",
    "url": "https://finnhub.io/api/news?id=df72b94d4eaa25c822358c9f4711103746db6dc03daa30527435c469c4cec93b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771417800,
      "headline": "BrainsWay Reports Cigna’s Evernorth Behavioral Health to Eliminate Prior Authorization Requirements for TMS Coverage, Accelerating Access to Care",
      "id": 139134272,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CI",
      "source": "Yahoo",
      "summary": "BURLINGTON, Mass. and JERUSALEM, Feb. 18, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today commented on the recent news issued by Evernorth® Behavioral Health, Inc., a division of the Cigna Group, which serves over 18 million covered lives across 12 states, that it will no longer require prior authorization for transcranial magnetic stimulation (TMS) for contracted providers",
      "url": "https://finnhub.io/api/news?id=df72b94d4eaa25c822358c9f4711103746db6dc03daa30527435c469c4cec93b"
    }
  },
  {
    "ts": null,
    "headline": "FDA chief Marty Makary says 'everything should be over the counter' unless drug is unsafe or addictive",
    "summary": "Makary said the FDA is looking at prescription drugs like nausea medications and vaginal estrogen, and hopes to make changes this year.",
    "url": "https://finnhub.io/api/news?id=04105639750ceec82f927ba72ef6ce83266b0d6af2f1fef117a869390c1457e0",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771404877,
      "headline": "FDA chief Marty Makary says 'everything should be over the counter' unless drug is unsafe or addictive",
      "id": 139137337,
      "image": "https://image.cnbcfm.com/api/v1/image/108111981-17412749682025-03-06t152858z_1041948067_rc2r7da7wjpm_rtrmadp_0_usa-trump-fda.jpeg?v=1741274989&w=1920&h=1080",
      "related": "CI",
      "source": "CNBC",
      "summary": "Makary said the FDA is looking at prescription drugs like nausea medications and vaginal estrogen, and hopes to make changes this year. ",
      "url": "https://finnhub.io/api/news?id=04105639750ceec82f927ba72ef6ce83266b0d6af2f1fef117a869390c1457e0"
    }
  },
  {
    "ts": null,
    "headline": "BrainsWay Notes Cigna's Evernorth Policy Shift Removing Prior Authorization For Transcranial Magnetic Stimulation, Effective March 2026; Highlights Access Expansion",
    "summary": "BrainsWay Ltd. (NASDAQ &amp; TASE: BWAY) (&#34;BrainsWay&#34; or the &#34;Company&#34;), a global leader in advanced noninvasive brain stimulation technologies, today commented on the recent news issued by Evernorth®",
    "url": "https://finnhub.io/api/news?id=ab6876fe1d27d43c8a0d8a7acb22987dbe8c9707c755e95a83fcf677fcbf92f1",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771403974,
      "headline": "BrainsWay Notes Cigna's Evernorth Policy Shift Removing Prior Authorization For Transcranial Magnetic Stimulation, Effective March 2026; Highlights Access Expansion",
      "id": 139134395,
      "image": "",
      "related": "CI",
      "source": "Benzinga",
      "summary": "BrainsWay Ltd. (NASDAQ &amp; TASE: BWAY) (&#34;BrainsWay&#34; or the &#34;Company&#34;), a global leader in advanced noninvasive brain stimulation technologies, today commented on the recent news issued by Evernorth®",
      "url": "https://finnhub.io/api/news?id=ab6876fe1d27d43c8a0d8a7acb22987dbe8c9707c755e95a83fcf677fcbf92f1"
    }
  }
]